Showing results (231-240 of 305) with videos related to

Sort By:
Pageof 31
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 3, 2015
HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladderI-Wei Chang, Peir-In Liang, Ching-Chia Li, et al.
Autophagy|June 30, 2018
Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesisH Helen Lin, Yiyin Chung, Chun-Ting Cheng, et al.
Cancer Medicine|December 22, 2015
The clinicopathological significance of NAB2-STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumorsShih-Chiang Huang, Chien-Feng Li, Yu-Chien Kao, et al.
Oncotarget|July 1, 2015
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancersJhih-Ying Chi, Yu-Wei Hsiao, Chien-Feng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2014
AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevanceChien-Feng Li, Fu-Min Fang, Jui Lan, et al.
Cancer Chemotherapy and Pharmacology|July 5, 2018
A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignanciesJames J Harding, Richard K Do, Imane El Dika, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2013
Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expressionDing-Ping Sun, Ching-Yih Lin, Yu-Feng Tian, et al.
Pageof 31